These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14625882)

  • 1. The end of the needle is in sight.
    Griffiths PD
    Rev Med Virol; 2003; 13(6):343-5. PubMed ID: 14625882
    [No Abstract]   [Full Text] [Related]  

  • 2. Triple infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus: a clinical challenge.
    Sterling RK
    Am J Gastroenterol; 2003 Oct; 98(10):2130-4. PubMed ID: 14572556
    [No Abstract]   [Full Text] [Related]  

  • 3. Does hepatitis C virus affect the reactivation of hepatitis B virus following renal transplantation?
    Yen TH; Huang CC; Lin HH; Huang JY; Tian YC; Yang CW; Wu MS; Fang JT; Yu CC; Chiang YJ; Chu SH
    Nephrol Dial Transplant; 2006 Apr; 21(4):1046-52. PubMed ID: 16390851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatitis B and C virus mutants. Clinical and therapeutical implications].
    Andreu J; Lissen E
    Gastroenterol Hepatol; 1995 Apr; 18(4):180-5. PubMed ID: 16541565
    [No Abstract]   [Full Text] [Related]  

  • 5. Current topics in hepatitis.
    Roggendorf M
    J Clin Virol; 2004 Apr; 30 Suppl 1():v-vi. PubMed ID: 15062767
    [No Abstract]   [Full Text] [Related]  

  • 6. [New guidelines, new strategies: the therapy of hepatitis B and C becomes easier].
    Jablonowski H
    MMW Fortschr Med; 2010 Apr; 152(17):65-7. PubMed ID: 20509267
    [No Abstract]   [Full Text] [Related]  

  • 7. Virology of hepatitis B and C viruses and antiviral targets.
    Pawlotsky JM
    J Hepatol; 2006; 44(1 Suppl):S10-3. PubMed ID: 16338022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Viral hepatitis B and hepatitis C and ultrastructural changes in infected hepatocytes].
    Skaro-Milić A; Dimitrijević J; Tufegdzić I; Nozić D
    Vojnosanit Pregl; 2002; 59(6 Suppl):39-45. PubMed ID: 12852145
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy and immunosuppression in patients with hepatitis B or C].
    Sitruk V; Fain O; Gordien E; Ganne-Carrié N; Deny P; Beaugrand M; Trinchet JC
    Gastroenterol Clin Biol; 2001 Nov; 25(11):1002-7. PubMed ID: 11845054
    [No Abstract]   [Full Text] [Related]  

  • 10. Feasibility of freeze-dried sera for serological and molecular biological detection of hepatitis B and C viruses.
    Ohishi W; Fujiwara S; Suzuki G; Kishi T; Sora M; Matsuura S; Hakoda M; Tatsukawa Y; Yamada M; Chayama K
    J Clin Microbiol; 2006 Dec; 44(12):4593-5. PubMed ID: 17035494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on chronic hepatitis: changing views on nomenclature and outcome.
    Govindarajan S
    Pathology (Phila); 1994; 3(1):1-22. PubMed ID: 9420889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of hepatitis B and C -- current standards].
    Zeuzem S
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S57-9. PubMed ID: 15368169
    [No Abstract]   [Full Text] [Related]  

  • 13. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
    J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBV-DNA in hemodialysis patients infected by HCV.
    Arababadi MK; Hassanshahi G; Yousefi H
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):398-401. PubMed ID: 19414941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Markers of hepatitis virus].
    Suzuki F
    Rinsho Byori; 2008 Nov; 56(11):1014-8. PubMed ID: 19086457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection.
    Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Bartolomé J; Pardo M; Carreño V
    J Med Virol; 2007 Mar; 79(3):236-41. PubMed ID: 17245725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult hepatitis B virus and hepatitis C virus infections.
    Carreño V; Bartolomé J; Castillo I; Quiroga JA
    Rev Med Virol; 2008; 18(3):139-57. PubMed ID: 18265423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sero-surveillance of HIV, HBV and HCV infections in antenatal and STD clinic attendees.
    Ganju SA; Goel A
    J Commun Dis; 2004 Mar; 36(1):60-2. PubMed ID: 16295688
    [No Abstract]   [Full Text] [Related]  

  • 19. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [When and how to treat hepatitis B and C?].
    Pache I; Hess J; Gonvers JJ; Moradpour D
    Rev Med Suisse; 2005 Jan; 1(3):237-41. PubMed ID: 15770818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.